🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

11,276 results for “Te” Clear

  1. TRALOKINUMAB, The placebo presentation is a pre-filled syringe containing the same excipients in the same amounts as the IMP.

    LEO Pharma A/S

    Atopic dermatitis and moderate-to severe atopic hand eczema

    approved small molecule active

    1 trial

  2. TRANEXAMIC ACID

    The George Institute

    Hip fracture

    approved small molecule active

    1 trial

  3. TYRX™ Absorbable Antibacterial Envelope

    Rhythm Pharmaceuticals Netherlands B.V.

    CIED Related Infection

    approved other completed

    1 trial

  4. Tadalafil

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    approved small molecule terminated

    1 trial

  5. Taneasy 600mg granules

    Biotech Pharmaceutical Co.,

    COPD (Chronic Obstructive Pulmonary Disease)

    approved small molecule completed

    1 trial

  6. Telaprevir

    Vertex Pharmaceuticals (Australia) Pty.

    Hepatitis C

    approved small molecule completed

    11 trials

  7. Telavancin

    Theravance Biopharma Ireland Umited

    End-Stage Renal Disease

    approved small molecule completed

    1 trial

  8. Telavancin Injection

    CUMBERLAND PHARMACEUTICALS INC

    Cystic Fibrosis

    approved small molecule completed

    1 trial

  9. Telavancin Injection

    CUMBERLAND PHARMACEUTICALS INC

    Subarachnoid Hemorrhage, Aneurysmal

    approved small molecule active

    1 trial

  10. Telbivudine treatment

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Hepatitis B

    approved small molecule completed

    1 trial

  11. Telmisartan

    Boehringer Ingelheim

    Cardiovascular Diseases

    approved small molecule completed

    1 trial

  12. Telmisartan/Amlodipine/Hydrochlorothiazide, Teldipin, 80 mg + 5 mg, tabletki, Telmisartan/Amlodipine/Hydrochlorothiazide, Tamloset 40 mg/5 mg tabletta, Tamloset 80 mg/10 mg tabletta, Telassmo 80 mg/10 mg tablete, Tamloset 80 mg/5 mg tabletta, Teldipin, 80 mg + 10 mg, tabletki, Telassmo 40 mg/5 mg tablete, Telmisartan/Amlodipine/Hydrochlorothiazide, Teldipin, 40 mg + 5 mg, tabletki, Telassmo 80 mg/5 mg tablete

    Novo Nordisk A/S

    Arterial hypertension

    approved small molecule active

    1 trial

  13. Temozolomide

    Monte Rosa Therapeutics

    Brain Neoplasms, Malignant, Primary

    approved small molecule completed

    1 trial

  14. Tenofovir Alafenamide 25 MG

    The First People's Hospital of Lianyungang

    Chronic Hepatitis C

    approved small molecule active

    1 trial

  15. Tenofovir Alafenamide Tablets

    The First People's Hospital of Lianyungang

    Chronic Hepatitis b

    approved small molecule active

    1 trial

  16. Tenofovir Alafenamide fumarate 25mg Oral Tablet

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Hepatitis B

    approved small molecule active

    1 trial

  17. Tenofovir disoproxil fumarate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Hepatitis B

    approved small molecule active

    1 trial

  18. Teriparatide

    United Therapeutics Europe Ltd

    Osteoporosis

    approved small molecule completed

    1 trial

  19. Teriparatide

    United Therapeutics Europe Ltd

    Stress Fracture of Tibia or Fibula

    approved small molecule active

    1 trial

  20. Terrosa 20 micrograms/80 microliters solution for injection in pre-filled pen, Acido Alendronico Aurobindo 70 mg compresse

    Gedeon Richter Australia Pty Ltd

    Prevention of new morphometric vertebral fractures and/or worsening of previous vertebral fractures.

    approved small molecule active

    1 trial

  21. Test preparation：Methylcholine chloroacetate for inhalation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy People

    approved small molecule completed

    1 trial

  22. Test preparation：Methylcholine chloroacetate for inhalation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Asthma

    approved small molecule completed

    1 trial

  23. Tetanusvaccin, suspensie voor injectie 40 IE

    Disc Medicine

    Systemic sclerosis, Systemic lupus erythematosus, Rheumatoid arthritis

    approved small molecule active

    1 trial

  24. The Placebo used for the clinical trial is a sterile saline solution (0.9% w/v solution of NaCl in water) supplied in 1.25 mL pre-filled glass syringes., Shingrix suspension for injection in pre filled syringe Herpes zoster vaccine (recombinant, adjuvanted), Shingrix powder and suspension for suspension for injection Herpes zoster vaccine (recombinant, adjuvanted)

    GlaxoSmithKline

    Incident dementia

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources